Safe reversal. 1. Atropine followed by neostigmine. An electrocardiographic study.
D000759:Adjuvants, Anesthesia / Q000494:pharmacology*; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001285:Atropine / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension; D007275:Injections, Intravenous; D009388:Neostigmine / Q000494:pharmacology*; D009609:Nitrous Oxide; D011175:Positive-Pressure Respiration; D014403:Tubocurarine / Q000494:pharmacology
D000759:Adjuvants, Anesthesia; D009388:Neostigmine; D001285:Atropine; D009609:Nitrous Oxide; D014403:Tubocurarine